← Dashboard
Oct 09, 2026 12:57 PM ET
Signal
Macro
City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs
Gene-silencing drugmaker seeks up to $185 million in U.S. IPO.
What changed
Gene-silencing drugmaker seeks up to $185 million in U.S. IPO.
Why it matters
Gene-silencing drugmaker seeks up to $185 million in U.S. IPO. — impact context not separately stored; see What changed.
Sources
qz
Related signals
STOCKS BOUNCE BACK FROM FED SELLOFF, NASDAQ SNAPS 6-DAY LOSING STREAK: LIVE UPDATES - CNBC →
SOUTH KOREA’S SK HYNIX RAISES $26.5BN IN RECORD-BREAKING US IPO - ALJAZEERA →
CAN CHINA FLASH MEMORY GIANT YMTC SMASH SHANGHAI STAR MARKET IPO RECORDS ? →